drugset / Trial / NCT00936962

Evaluation of Meningococcal C Vaccine Programmes in Canadian Children

NCT00936962

Non-randomizedSingle-groupOpen-label

Summary

The purpose of the study is to see which of the three current provincial Meningococcal C Conjugate vaccine schedules in Canada provide the longest lasting protection against Meningococcal C disease and to see if a booster vaccination is needed.

Timeline

Start
2009-07
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject NeisVac-C Vaccine 0.5 ml Intramuscular